Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Abbvie sings $1.1bn Alzheimer's partnership, Shire, Microsoft and EURORDIS form new rare disease alliance, and Greek parliament moves to investigate...
NICE has recommended that three separate treatments for thyroid cancer should be made available for use of the NHS: Ipsen’s Cometriq (cabozantinib...
Rare disease specialist pharma firm Shire, rare disease patient alliance EURORDIS and tech giant Microsoft have announced they have formed a...
The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, a new study has found.

Features

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the migraine space to...

Appointments

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches